The number of future sales ( besides the necessary EPA approval ) hinges of what you already discussed many months ago. Namely, what is the monetary value to a Hospital?
What Medizone should be doing, or should have already done, is to document the cost to treat each person during the Belleville MRSA outbreak. Then present that to the media. They have to show that besides keeping an OR suite clean, they must be able to prove that the Hospital will save money with prevention rather than treatment, permanent illness and death.
Besides money, they will need to prove to the CDC and Insurance companies that this is the best method to completely eradicate all Superbugs.
From a medical perspective, failure to provide the best diagnostic tools available leaves the practitioner vulnerable to liabilities.
As to the number of sales, I would say that we will get a nice jump with 40 units being sold. However, there would also need to be additional sales of AT LEAST 5 units per month. A one time 40 unit procurement will not support the stock for very long. I think 40 units could jump the SP up to about .40 cents from here. But it will quickly slip back into the .20's without more sales.
I agree that 300 would get us up to, and maybe over, $1.00 but that also wont hold for long.
First, lets get EPA approval.
News 
Market Data 
Discover 
